Company Filing History:
Years Active: 2022
Title: Anja Koester: Innovator in Therapeutic Antibodies
Introduction
Anja Koester is a notable inventor based in the United States. He has made significant contributions to the field of therapeutic antibodies, particularly in the development of treatments for various diseases. His innovative work focuses on the use of anti-human CD200R agonist antibodies.
Latest Patents
Anja Koester holds a patent titled "Cd200r Agonist Antibodies And Uses Thereof." This invention relates to anti-human CD200R agonist antibodies and their applications in treating diseases such as atopic dermatitis, chronic spontaneous urticaria, allergy, asthma, scleroderma, inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), multiple sclerosis (MS), rheumatoid arthritis (RA), graft-versus-host disease (GvHD), and psoriasis. Although he currently has 1 patents, his work in this area is promising.
Career Highlights
Throughout his career, Anja Koester has focused on advancing therapeutic options for patients suffering from chronic and complex diseases. His research has the potential to improve the quality of life for many individuals affected by these conditions.
Collaborations
Anja Koester has collaborated with notable colleagues, including Stephen John Demarest and Payal Mehta. These partnerships have contributed to the development and refinement of his innovative therapeutic approaches.
Conclusion
Anja Koester is an influential figure in the field of therapeutic antibodies, with a focus on innovative treatments for various diseases. His work continues to pave the way for advancements in medical science and patient care.